Jan 05, 2021 / 12:00PM GMT
Keyur Parekh - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Good morning, good afternoon, and thank you, everybody, for joining us. My name is Keyur Parekh, and I cover GlaxoSmithKline for Goldman Sachs with our London offices. It's my pleasure to host Dame Emma Walmsley for this inaugural chat. But before we kick it off, I'm required to make certain disclaimers.
Goldman Sachs agrees to host this conference on the basis that no third-party speaker will provide confidential or material nonpublic information. In addition, by attending this confidence, we provide Goldman Sachs the right to record and redistribute the conference information. The views of third-party speakers do not necessarily reflect those of Goldman Sachs.
We are required to make certain disclosures in public appearances about Goldman Sachs' relationship with companies that we discuss, the disclosures related to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer upon request. However, these disclosures are available in
GlaxoSmithKline PLC at Goldman Sachs Healthcare CEOs Unscripted Conference (Virtual) Transcript
Jan 05, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers